Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60611


Purpose:

The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.


Study summary:

The goal of this prospective randomized study is to compare whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain (sizes 1.5 and 2) and the Laryngeal Mask Airway (LMA) Supreme. Parameters of clinical relevance such as insertion success rates, fiberoptic view of the glottic opening, ease and speed of gastric tube placement, airway stability, and peri-operative complications will also be assessed.


Criteria:

Inclusion Criteria: - Scheduled for surgery utilizing a supraglottic airway device - ASA (American Society of Anesthesiologists) I-III classification - Weighing between 5 - 20 kilograms Exclusion Criteria: - Active respiratory infection - History of difficult mask ventilation - Diagnosis of congenital syndrome with difficult airway management - Active gastrointestinal reflux - Coagulopathy - Significant Pulmonary disease - Emergent surgery


NCT ID:

NCT02380768


Primary Contact:

Principal Investigator
Narasimhan Jagannathan, M.D.
Ann & Robert H Lurie Children's Hospital of Chicago


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.